Novonesis (Novozymes) B (CHIX:NSISBC) Other Long Term Assets : kr2,381 Mil (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Novonesis (Novozymes) B Other Long Term Assets?

Novonesis (Novozymes) B's other long-term assets for the quarter that ended in Mar. 2025 was kr2,381 Mil.

Novonesis (Novozymes) B's quarterly other long-term assets increased from Jun. 2024 (kr2,351 Mil) to Dec. 2024 (kr2,414 Mil) but then stayed the same from Dec. 2024 (kr2,414 Mil) to Mar. 2025 (kr2,381 Mil).

Novonesis (Novozymes) B's annual other long-term assets increased from Dec. 2022 (kr1,967 Mil) to Dec. 2023 (kr2,073 Mil) and increased from Dec. 2023 (kr2,073 Mil) to Dec. 2024 (kr2,414 Mil).

Novonesis (Novozymes) B Other Long Term Assets Historical Data

The historical data trend for Novonesis (Novozymes) B's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Other Long Term Assets Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

1,432.66

1,734.74

1,966.99

2,072.80

2,414.06

Novonesis (Novozymes) B Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															2,072.80	-	2,351.01	2,414.06	2,380.82

Novonesis (Novozymes) B Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (CHIX:NSISBc) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA 0Q4U:UK NSIS B:Denmark NZM:Germany NZM:Germany NZM2:Germany NZM2:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines